Precision oncology startup Abdera launches with seed round

Vancouver-based precision oncology company Abdera Therapeutics has launched with a seed-stage financing of C$8 million.

26 January 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles